Skip to content

Effect of different doses of esketamine on postoperative recovery quality in gynecological laparoscopic surgery

Effect of different doses of esketamine on postoperative recovery quality in gynecological laparoscopic surgery

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400082718
Enrollment
Unknown
Registered
2024-04-07
Start date
2024-04-07
Completion date
Unknown
Last updated
2024-04-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with gynecological diseases

Interventions

Low dose of esketamine:0.25mg/kg esketamine
medium dose of esketamine:0.5mg/kg esketamine
control group:normal saline

Sponsors

Anhui Number 2 Province People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Age: 18 ~70 years old; BMI: 18~30kg/m2; ASA grade I~III; Laparoscopic gynecological surgery under elective general anesthesia; Volunteer to participate in the study and sign the informed consent.

Exclusion criteria

Exclusion criteria: Allergies to the drugs used in this study; Inability to communicate before surgery due to cognitive or language impairment; Heart, liver or kidney dysfunction; Untreated or poorly controlled high blood pressure; Glaucoma, elevated intracranial pressure, hyperthyroidism, or alcohol abuse; Esketamine contraindications (arteriosclerosis, coronary heart disease, cardiac insufficiency, pulmonary heart disease, pulmonary hypertension, etc.)

Design outcomes

Primary

MeasureTime frame
postoperative quality of recovery score;

Secondary

MeasureTime frame
VAS;MAP;HR;

Countries

China

Contacts

Public ContactLi Tingting

Anhui Number 2 Province People's Hospital

2210205719@qq.com+86 159 5682 5112

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026